Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Neoplasms, Germ Cell and Embryonal D009373 4 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Nerve Degeneration D009410 53 associated lipids
Nervous System Diseases D009422 37 associated lipids
Neuralgia D009437 28 associated lipids
Neuroblastoma D009447 66 associated lipids
Neurologic Manifestations D009461 1 associated lipids
Neutropenia D009503 15 associated lipids
Osteonecrosis D010020 5 associated lipids
Pain D010146 64 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Pancreatitis D010195 10 associated lipids
Parkinson Disease D010300 53 associated lipids
Aggressive Periodontitis D010520 8 associated lipids
Peritonitis D010538 38 associated lipids
Platelet Storage Pool Deficiency D010981 3 associated lipids
Pleurisy D010998 20 associated lipids
Pneumococcal Infections D011008 7 associated lipids
Pneumonia, Pneumococcal D011018 3 associated lipids
Polycythemia Vera D011087 13 associated lipids
Pregnancy Complications, Cardiovascular D011249 11 associated lipids
Pregnancy Complications, Hematologic D011250 11 associated lipids
Proteinuria D011507 30 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Psoriasis D011565 47 associated lipids
Pulmonary Edema D011654 23 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Purpura, Thrombotic Thrombocytopenic D011697 6 associated lipids
Respiratory Distress Syndrome, Adult D012128 15 associated lipids
Respiratory Hypersensitivity D012130 18 associated lipids
Rheumatic Diseases D012216 7 associated lipids
Rhinitis D012220 10 associated lipids
Salmonella Infections, Animal D012481 9 associated lipids
Osteosarcoma D012516 50 associated lipids
Scleroderma, Systemic D012595 16 associated lipids
Seizures D012640 87 associated lipids
Shock D012769 11 associated lipids
Shock, Cardiogenic D012770 5 associated lipids
Shock, Septic D012772 11 associated lipids
Shock, Traumatic D012774 4 associated lipids
Sneezing D012912 6 associated lipids
Spasm D013035 5 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Staphylococcal Skin Infections D013207 9 associated lipids
Stomach Ulcer D013276 75 associated lipids
Stomatitis D013280 14 associated lipids
Subacute Sclerosing Panencephalitis D013344 3 associated lipids
Subarachnoid Hemorrhage D013345 17 associated lipids
Tangier Disease D013631 8 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Han JI et al. RGS1 and RGS13 mRNA silencing in a human B lymphoma line enhances responsiveness to chemoattractants and impairs desensitization. 2006 J. Leukoc. Biol. pmid:16565322
Vahidy WH et al. Effects of intracerebroventricular injections of free fatty acids, lysophospholipids, or platelet activating factor in a mouse model of orofacial pain. 2006 Exp Brain Res pmid:16947060
Purnell ET et al. Influence of the preimplantation embryo development (Ped) gene on embryonic platelet-activating factor (PAF) levels. 2006 J. Assist. Reprod. Genet. pmid:16799834
Balestrieri C et al. Relative effects of phenolic constituents from Yucca schidigera Roezl. bark on Kaposi's sarcoma cell proliferation, migration, and PAF synthesis. 2006 Biochem. Pharmacol. pmid:16580641
Antonopoulou S et al. Effect of traditional Greek Mediterranean meals on platelet aggregation in normal subjects and in patients with type 2 diabetes mellitus. 2006 J Med Food pmid:17004898
Louis NA et al. Lipid mediator networks and leukocyte transmigration. 2005 Sep-Oct Prostaglandins Leukot. Essent. Fatty Acids pmid:15979294
Spitzer AL et al. Early nonenhanced abdominal computed tomography can predict mortality in severe acute pancreatitis. 2005 Sep-Oct J. Gastrointest. Surg. pmid:16137586
Akyürek N et al. The effect of platelet activating factor antagonist BN 52021 on bacterial translocation and ICAM-I expression in experimental obstructive jaundice. 2005 Sep-Oct J Invest Surg pmid:16249168
O'Neill C The role of paf in embryo physiology. 2005 May-Jun Hum. Reprod. Update pmid:15790601
Krasheninnikov ME and Pliashkevich IuG [Effects of the platelet activating factor on the proliferation and IgE secretion by U-266BL human myeloma cells]. 2005 Jul-Aug Eksp Klin Farmakol pmid:16193656
Marrache AM et al. Intracellular signaling of lipid mediators via cognate nuclear G protein-coupled receptors. 2005 Jan-Apr Endothelium pmid:16036317
Owen JS et al. An improved assay for platelet-activating factor using HPLC-tandem mass spectrometry. 2005 J. Lipid Res. pmid:15520455
Lemieux C et al. Angiopoietins can directly activate endothelial cells and neutrophils to promote proinflammatory responses. 2005 Blood pmid:15498854
Bazan HE Cellular and molecular events in corneal wound healing: significance of lipid signalling. 2005 Exp. Eye Res. pmid:15781273
Oku H et al. Inhibitory effects of xanthones from guttiferae plants on PAF-induced hypotension in mice. 2005 Planta Med. pmid:15678383
Lin P et al. Lysophosphatidylcholine modulates neutrophil oxidant production through elevation of cyclic AMP. 2005 J. Immunol. pmid:15728511
Shimada T et al. Platelet-activating factor acts on cortisol secretion by perfused guinea-pig adrenals via calcium-/phospholipid-dependent mechanisms. 2005 J. Endocrinol. pmid:15684346
Yasu T et al. Activated leukocytes and endothelial cells enhance retention of ultrasound contrast microspheres containing perfluoropropane in inflamed venules. 2005 Int. J. Cardiol. pmid:15686774
Fell JM Neonatal inflammatory intestinal diseases: necrotising enterocolitis and allergic colitis. 2005 Early Hum. Dev. pmid:15707723
Schaloske RH et al. Molecular characterization of the lipopolysaccharide/platelet activating factor- and zymosan-induced pathways leading to prostaglandin production in P388D1 macrophages. 2005 Biochim. Biophys. Acta pmid:15708354
Mann NS and Leung JW Pathogenesis of esophageal rings in eosinophilic esophagitis. 2005 Med. Hypotheses pmid:15617859
Cheng L et al. Platelet-activating factor and prostaglandin E2 impair esophageal ACh release in experimental esophagitis. 2005 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:15890711
Fulkerson PC et al. CXCL9 inhibits eosinophil responses by a CCR3- and Rac2-dependent mechanism. 2005 Blood pmid:15802529
White DC et al. Feasibility of assessment of regulatory lipids in breath condensate as potential presymptomatic harbingers of pulmonary pathobiology. 2005 J. Microbiol. Methods pmid:15963585
Jeon SY et al. Rat model of platelet-activating factor-induced rhinosinusitis. 2005 Ann. Otol. Rhinol. Laryngol. pmid:15966528
Tiemann U et al. Influence of ovarian steroid hormones or platelet-activating factor on mRNA of platelet-activating factor receptor in endometrial explant perfusion cultures from ovariectomized bovine. 2005 Prostaglandins Other Lipid Mediat. pmid:15967160
Lang KS et al. Mechanisms of suicidal erythrocyte death. 2005 Cell. Physiol. Biochem. pmid:15956782
Kita Y et al. A multiplex quantitation method for eicosanoids and platelet-activating factor using column-switching reversed-phase liquid chromatography-tandem mass spectrometry. 2005 Anal. Biochem. pmid:15958190
Fang YH et al. [Relationship between serum vWF and PAF in type 2 diabetic patients and diabetic nephropathy]. 2005 Di Yi Jun Yi Da Xue Xue Bao pmid:15958323
Vinson SM et al. Neutrophil adherence to bladder microvascular endothelial cells following platelet-activating factor acetylhydrolase inhibition. 2005 J. Pharmacol. Exp. Ther. pmid:15937147
Sumita C et al. Platelet activating factor induces cytoskeletal reorganization through Rho family pathway in THP-1 macrophages. 2005 FEBS Lett. pmid:16004986
Ou-Yang XY et al. [Inhibitory effect of ginkgolide B on angiogenesis in chronic inflammation]. 2005 Yao Xue Xue Bao pmid:16011257
Echazarreta AL et al. Lack of systemic oxidative stress during PAF challenge in mild asthma. 2005 Respir Med pmid:15823446
Cao HC et al. Determination of platelet-activating factor by reverse phase high-performance liquid chromatography and its application in viral hepatitis. 2005 World J. Gastroenterol. pmid:16437644
Vardar S et al. Individual and combined effects of selective cyclooxygenase-2 inhibitor and omega-3 fatty acid on endotoxin-induced periodontitis in rats. 2005 J. Periodontol. pmid:15830643
Rubin BB et al. Cytosolic phospholipase A2-alpha is necessary for platelet-activating factor biosynthesis, efficient neutrophil-mediated bacterial killing, and the innate immune response to pulmonary infection: cPLA2-alpha does not regulate neutrophil NADPH oxidase activity. 2005 J. Biol. Chem. pmid:15475363
Zinchuk O et al. Direct action of platelet activating factor (PAF) induces eosinophil accumulation and enhances expression of PAF receptors in conjunctivitis. 2005 Mol. Vis. pmid:15735601
Connelly PW et al. Paraoxonase-1 does not reduce or modify oxidation of phospholipids by peroxynitrite. 2005 Free Radic. Biol. Med. pmid:15607900
Ivanov AI et al. Albumin is not an irreplaceable carrier for amphipathic mediators of thermoregulatory responses to LPS: compensatory role of alpha1-acid glycoprotein. 2005 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:15576666
Denizot Y et al. Platelet-activating factor does not stimulate cAMP formation from immature forms of freshly isolated leukaemic blasts. 2005 Leuk. Lymphoma pmid:15621790
Tran KC et al. Induction of angiogenesis by platelet-activating factor in the rat striatum. 2005 Neuroreport pmid:16148749
Milias GA et al. Effects of eccentric exercise-induced muscle injury on blood levels of platelet activating factor (PAF) and other inflammatory markers. 2005 Eur. J. Appl. Physiol. pmid:16151835
Hauser CJ et al. Non-specific effects of 4-chloro-m-cresol may cause calcium flux and respiratory burst in human neutrophils. 2005 Biochem. Biophys. Res. Commun. pmid:16168959
Kihara Y et al. Dual phase regulation of experimental allergic encephalomyelitis by platelet-activating factor. 2005 J. Exp. Med. pmid:16172262
Tian X and Bazan NG Neuroprotection by platelet-activating factor antagonism. 2005 Ann. N. Y. Acad. Sci. pmid:16179552
Zhang Q et al. Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor. 2005 J. Clin. Invest. pmid:16184199
Pexa A and Deussen A Modulation of ecto-5'-nucleotidase by phospholipids in human umbilical vein endothelial cells (HUVEC). 2005 Naunyn Schmiedebergs Arch. Pharmacol. pmid:16200394
Tunc SE et al. Platelet-activating factor and P-selectin activities in thrombotic and nonthrombotic Behçet's patients. 2005 Rheumatol. Int. pmid:15004723
Hu G et al. Isoflurane prevents platelets from enhancing neutrophil-induced coronary endothelial dysfunction. 2005 Anesth. Analg. pmid:16243978
Löhrke B et al. Polar phospholipids from bovine endogenously oxidized low density lipoprotein interfere with follicular thecal function. 2005 J. Mol. Endocrinol. pmid:16326838